"transendocardial" meaning in All languages combined

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "trans",
        "3": "endocardial"
      },
      "expansion": "trans- + endocardial",
      "name": "prefix"
    }
  ],
  "etymology_text": "trans- + endocardial",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "transendocardial (not comparable)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms prefixed with trans-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Anatomy",
          "orig": "en:Anatomy",
          "parents": [
            "Biology",
            "Medicine",
            "Sciences",
            "All topics",
            "Fundamental"
          ],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2015 August 8, Ozge Kizilay Mancini et al., “Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression”, in Stem Cell Research & Therapy, volume 6, →DOI",
          "text": "2 Reduced MSC-mediated T-cell suppression capacity in patients with atherosclerosis and type 2 diabetes. a MSCs from patients with atherosclerosis (ATH; n = 18; * p = 0.02) have a decreased capacity to suppress CD4 + T-cell proliferation at 1:8 MSC:CD4 + T cell ratio compared to age-matched controls without atherosclerosis (non-ATH, n = 9). b MSCs from patients with ATH (n = 12) and type 2 diabetes mellitus (T2DM) (n = 12) have impaired suppressive capacity compared to age-matched ATH controls (* p = 0.04). c MSC function is compromised in age-matched patients with chronic inflammatory diseases (non-ATH < ATH < ATH+T2DM; n = 7 per group; * p = 0.02, ** p = 0.002) The PRECISE trial demonstrated the feasibility, safety and potential therapeutic benefit of the transendocardial administration of autologous adipose-derived MSCs in no-option patients with ischemic cardiomyopathy [ 7 ].",
          "type": "quotation"
        }
      ],
      "glosses": [
        "Through or across the endocardium"
      ],
      "id": "en-transendocardial-en-adj-ED4CWc5-",
      "links": [
        [
          "anatomy",
          "anatomy"
        ],
        [
          "endocardium",
          "endocardium"
        ]
      ],
      "raw_glosses": [
        "(anatomy) Through or across the endocardium"
      ],
      "tags": [
        "not-comparable"
      ],
      "topics": [
        "anatomy",
        "medicine",
        "sciences"
      ]
    }
  ],
  "word": "transendocardial"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "trans",
        "3": "endocardial"
      },
      "expansion": "trans- + endocardial",
      "name": "prefix"
    }
  ],
  "etymology_text": "trans- + endocardial",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "transendocardial (not comparable)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "categories": [
        "English adjectives",
        "English entries with incorrect language header",
        "English lemmas",
        "English terms prefixed with trans-",
        "English terms with quotations",
        "English uncomparable adjectives",
        "en:Anatomy"
      ],
      "examples": [
        {
          "ref": "2015 August 8, Ozge Kizilay Mancini et al., “Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression”, in Stem Cell Research & Therapy, volume 6, →DOI",
          "text": "2 Reduced MSC-mediated T-cell suppression capacity in patients with atherosclerosis and type 2 diabetes. a MSCs from patients with atherosclerosis (ATH; n = 18; * p = 0.02) have a decreased capacity to suppress CD4 + T-cell proliferation at 1:8 MSC:CD4 + T cell ratio compared to age-matched controls without atherosclerosis (non-ATH, n = 9). b MSCs from patients with ATH (n = 12) and type 2 diabetes mellitus (T2DM) (n = 12) have impaired suppressive capacity compared to age-matched ATH controls (* p = 0.04). c MSC function is compromised in age-matched patients with chronic inflammatory diseases (non-ATH < ATH < ATH+T2DM; n = 7 per group; * p = 0.02, ** p = 0.002) The PRECISE trial demonstrated the feasibility, safety and potential therapeutic benefit of the transendocardial administration of autologous adipose-derived MSCs in no-option patients with ischemic cardiomyopathy [ 7 ].",
          "type": "quotation"
        }
      ],
      "glosses": [
        "Through or across the endocardium"
      ],
      "links": [
        [
          "anatomy",
          "anatomy"
        ],
        [
          "endocardium",
          "endocardium"
        ]
      ],
      "raw_glosses": [
        "(anatomy) Through or across the endocardium"
      ],
      "tags": [
        "not-comparable"
      ],
      "topics": [
        "anatomy",
        "medicine",
        "sciences"
      ]
    }
  ],
  "word": "transendocardial"
}